QI
RPTP

Quotient Investors’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Quotient Investors’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-12,900
Closed -$136K – 293
2014
Q4 		$136K Sell
12,900
-8,300
-39% -$81.1K 0.03% 237
2014
Q3 		$203K Buy
+21,200
New +$216K 0.04% 212

Other funds holding RPTP

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Quotient Investors's RPTP Position: Q1 2015 in Review

Quotient Investors sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q1 2015, closing a stake of 12,900 shares — an estimated $136K sold.

Quotient Investors first reported a position in RPTP in Q3 2014 and held it in 2 quarters. The position peaked at $203K in Q3 2014. 75 funds tracked by Wall St. Rank hold RPTP as of Q1 2015.

  • Quotient Investors reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q1 2015 after selling out during the quarter.
  • Quotient Investors sold 12,900 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q1 2015, an estimated $136K.
  • Quotient Investors first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2014 and held it in 2 quarters.
  • Quotient Investors's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $203K in Q3 2014.
  • 75 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q1 2015.

Based on Quotient Investors's 13F filing for Q1 2015, filed 10 Apr 2015.